Literature DB >> 27101352

'Bedside assessment' of acute hantavirus infections and their possible classification into the spectrum of haemophagocytic syndromes.

J Clement1, P Colson2, V Saegeman3,4, K Lagrou3,4, M Van Ranst5,3,4.   

Abstract

Hantavirus infections, recently renamed 'hantavirus fever' (HTVF), belong to the most common but also most underestimated zoonoses in the world. A small number of reports described the so-called 'lipid paradox' in HTVF, i.e. the striking contrast between a very low serum total cholesterol and/or high-density lipoprotein cholesterol (HDLc), and a paradoxical concomitant hypertriglyceridaemia. In a prospective study, with patients being their own control after illness, we wanted to verify if this quick and easy 'bedside test' was robust enough to warrant a preliminary diagnosis of acute kidney injury (AKI) caused by HTVF. The study cohort consisted of 58 Belgian cases (mean age 44 years), admitted with varying degrees of AKI and of thrombocytopaenia, both characteristic for presumptive HTVF. All cases were sero-confirmed as having acute HTVF. At or shortly after hospital admission, a significant (p < 0.001) decrease of total cholesterol and HDLc was found in comparison with normalised levels in the same cohort, quantified a few days after spontaneous AKI recovery. Conversely, fasting triglyceride levels during HTVF infection were significantly (p < 0.001) higher during illness than after recovery. This 'lipid paradox' was most outspoken in severe HTVF cases, often accompanying, or even predicting, major kidney or lung complications. Thus, this 'bedside assessment' seems to hold even promise for presumptive diagnosis of more severe so-called 'hantavirus cardio-pulmonary syndrome' (HCPS) cases, mostly described hitherto in the New World. In more severe AKI cases, the mean total cholesterol was significantly lower (p = 0.02) than in milder cases, i.e. cases with peak serum creatinine levels of < 1.5 mg/dL. Thrombocytopaenia, generally accepted as the severity index in HTVF, appeared, moreover, significantly correlated with serum levels of total cholesterol (R = 0.52, p < 0.001) and with serum levels of HDLc (R = 0.45, p < 0.01). A link with the novel clinical entity of haemophagocytic syndromes, also characterised by manifest hypertriglyceridaemia, is discussed.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27101352     DOI: 10.1007/s10096-016-2638-4

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  36 in total

Review 1.  Hantavirus.

Authors:  Jan P Clement
Journal:  Antiviral Res       Date:  2003-01       Impact factor: 5.970

Review 2.  Hantaviruses: immunology, treatment, and prevention.

Authors:  Piet Maes; Jan Clement; Irina Gavrilovskaya; Marc Van Ranst
Journal:  Viral Immunol       Date:  2004       Impact factor: 2.257

Review 3.  Hemophagocytic lymphohistiocytosis (HLH): A heterogeneous spectrum of cytokine-driven immune disorders.

Authors:  Ellen Brisse; Carine H Wouters; Patrick Matthys
Journal:  Cytokine Growth Factor Rev       Date:  2014-10-28       Impact factor: 7.638

4.  Leptospirosis versus hantavirus infections in the Netherlands and in Belgium, 2000 to 2014.

Authors:  J Clement; M Van Esbroeck; K Lagrou; J Verschueren; N P Sunil-Chandra; M Van Ranst
Journal:  Euro Surveill       Date:  2014-09-25

5.  Serum lipids in muroid virus nephropathy.

Authors:  B Hory; J M Estavoyer; N Cardot; G Couetdic
Journal:  Nephron       Date:  1988       Impact factor: 2.847

6.  Tumor necrosis factor-alpha genetic predisposing factors can influence clinical severity in nephropathia epidemica.

Authors:  Piet Maes; Jan Clement; Paul H P Groeneveld; Paul Colson; Tom W J Huizinga; Marc Van Ranst
Journal:  Viral Immunol       Date:  2006       Impact factor: 2.257

7.  Epidemiology and laboratory diagnosis of hantavirus (HTV) infections.

Authors:  J Clement; P McKenna; J Groen; A Osterhaus; P Colson; T Vervoort; G van der Groen; H W Lee
Journal:  Acta Clin Belg       Date:  1995       Impact factor: 1.264

8.  Concomitant leptospirosis-hantavirus co-infection in acute patients hospitalized in Sri Lanka: implications for a potentially worldwide underestimated problem.

Authors:  N P Sunil-Chandra; J Clement; P Maes; H J DE Silva; M VAN Esbroeck; M VAN Ranst
Journal:  Epidemiol Infect       Date:  2015-01-13       Impact factor: 4.434

9.  Hantavirus infections in humans and animals, China.

Authors:  Yong-Zhen Zhang; Yang Zou; Zhen F Fu; Alexander Plyusnin
Journal:  Emerg Infect Dis       Date:  2010-08       Impact factor: 6.883

10.  Hantavirus nephropathy as a pseudo-import pathology from Ecuador.

Authors:  R Demeester; E Bottieau; M Van Esbroeck; M R Pourkarim; P Maes; J Clement
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-10-11       Impact factor: 5.103

View more
  4 in total

1.  High Triglycerides Are Associated with Low Thrombocyte Counts and High VEGF in Nephropathia Epidemica.

Authors:  Ekaterina V Martynova; Aygul H Valiullina; Oleg A Gusev; Yuriy N Davidyuk; Ekaterina E Garanina; Venera G Shakirova; Ilsiyar Khaertynova; Vladimir A Anokhin; Albert A Rizvanov; Svetlana F Khaiboullina
Journal:  J Immunol Res       Date:  2016-12-05       Impact factor: 4.818

Review 2.  Wild Rats, Laboratory Rats, Pet Rats: Global Seoul Hantavirus Disease Revisited.

Authors:  Jan Clement; James W LeDuc; Graham Lloyd; Jean-Marc Reynes; Lorraine McElhinney; Marc Van Ranst; Ho-Wang Lee
Journal:  Viruses       Date:  2019-07-17       Impact factor: 5.048

3.  Transient hypertriglyceridemia: a common finding during Epstein-Barr virus-induced infectious mononucleosis.

Authors:  Emilio-Manuel Páez-Guillán; Joaquín Campos-Franco; Rosario Alende; Yago Garitaonaindía; Arturo González-Quintela
Journal:  Lipids Health Dis       Date:  2021-12-12       Impact factor: 3.876

4.  Domestically Acquired Seoul Virus Causing Hemophagocytic Lymphohistiocytosis-Washington, DC, 2018.

Authors:  Bhagyashree Shastri; Aaron Kofman; Andrew Hennenfent; John D Klena; Stuart Nicol; James C Graziano; Maria Morales-Betoulle; Deborah Cannon; Agueda Maradiaga; Anthony Tran; Sheena K Ramdeen
Journal:  Open Forum Infect Dis       Date:  2019-09-21       Impact factor: 3.835

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.